Why is Thyrocare Tech. falling/rising?

As of 07-Jul, Thyrocare Technologies Ltd is experiencing a price increase, currently at Rs. 1,085.00, reflecting a rise of 74.0 points or 7.32%. The stock has reached a new 52-week high today and has outperformed its sector by 7.03%. Over the past week, Thyrocare has shown a return of +9.70%, significantly higher than the Sensex, which has declined by 0.20%. The company has demonstrated strong performance metrics, including a high return on equity (ROE) of 20.45%, and has reported positive results for the last five consecutive quarters, contributing to its recent price movement. However, it is important to note that the stock has a high price-to-book value and a PEG ratio of 2.1, indicating a potentially expensive valuation compared to its peers.
In the broader market context, Thyrocare's short-term performance has been robust, with a 1-month return of +13.84% compared to the Sensex's +1.53%. This indicates that the stock is not only performing well in isolation but is also gaining traction against the market benchmark. Despite the positive indicators, there are risks such as poor long-term growth in operating profit and the fact that 100% of promoter shares are pledged, which could exert downward pressure in adverse market conditions. Overall, while the stock is currently rising due to strong operational performance and market positioning, the concerns regarding valuation and promoter share pledging could pose challenges in the future.